Prism Bio-Medicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.80 M
- Company Age 21 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.50 M
- Revenue Growth 14.84%
- Profit Growth 124.58%
- Ebitda 51.68%
- Net Worth 17.35%
- Total Assets 31.38%
About Prism Bio-Medicals
Prism Bio-Medicals Private Limited (PBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 28 October 2003 and has a history of 21 years and three months. Its registered office is in Bangalore, Karnataka, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.80 M.
The company currently has active open charges totaling ₹3.50 M.
Champalal Jain and Ganeshan Ramachandran serve as directors at the Company.
Company Details
-
Location
Bangalore, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U73100KA2003PTC032793
-
Company No.
032793
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Oct 2003
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
What products or services does Prism Bio-Medicals Private Limited offer?
Prism Bio-Medicals Private Limited offers a wide range of products and services, including Laboratory Bath, Hematology Analyzers, Coagulation Analyzers, Cell Counter, Elemental Analyzer, Analyzer Equipment, Lab Incubator, Platelet Incubator, Biochemistry Analyzer, Fully Automated Biochemistry Analyzer.
Who are the key members and board of directors at Prism Bio-Medicals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ganeshan Ramachandran
|
Director | 28-Oct-2003 | Current |
|
Champalal Jain
|
Director | 28-Oct-2003 | Current |
Financial Performance of Prism Bio-Medicals.
Prism Bio-Medicals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 14.84% increase. The company also saw a substantial improvement in profitability, with a 124.58% increase in profit. The company's net worth Soared by an impressive increase of 17.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Prism Bio-Medicals?
Unlock access to Prism Bio-Medicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹3.50 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.35 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Nov 2022 | Hdfc Bank Limited | ₹3.50 M | Open |
How Many Employees Work at Prism Bio-Medicals?
Unlock and access historical data on people associated with Prism Bio-Medicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prism Bio-Medicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prism Bio-Medicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.